Login / Signup

A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints.

Naoki IsogawaKentaro TakedaKazushi MaruoTakashi Daimon
Published in: Therapeutic innovation & regulatory science (2019)
To make use of historical control data, if importance is attached to control of the TIE rate, the meta-analytic approach using a normal-normal hierarchical model may be preferable to the power prior approach, whereas if attached to improvement of the power, this preference be reversed. Anyway, the best approach should be chosen by comparing the operational characteristics of the approaches.
Keyphrases
  • clinical trial
  • randomized controlled trial
  • healthcare
  • electronic health record
  • big data
  • machine learning
  • open label
  • social media
  • phase iii